Oculus Innovative Sciences Launches Microcyn(R) Dermatology HydroGel for Relief of Pain and Itch into U.S. Dermatology Healthcare Market Mar 25, 2010
Oculus Innovative Sciences to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference Mar 11, 2010
Oculus Innovative Sciences Receives First FDA Clearance for Microcyn(R)-Based HydroGel for Dermatology Market with Claims Including Reduction of Itch and Pain Relief Mar 10, 2010
Oculus Innovative Sciences Reports Third Quarter FY 2010 Financial Results: 30% Reduction in Operating Expenses and 36% Increase in Product Revenue Feb 4, 2010
Oculus Innovative Sciences Introduces Microcyn(R) Solution for Use in Post-Surgical Wounds to U.S. Hospitals and Physicians Jan 28, 2010
Oculus Innovative Sciences Announces Fiscal Third Quarter 2010 Financial Results and Corporate Update Release and Conference Call Jan 26, 2010
Oculus Innovative Sciences to Present at OneMed Forum 2010 During JP Morgan Week in San Francisco Jan 7, 2010
Oculus Innovative Sciences' Development Partner, Bayer Animal Health, Receives Regulatory Approvals to Market Microcyn(R)-Based Vetericyn(TM) Animal Healthcare Products in China and Taiwan Nov 13, 2009
Oculus Innovative Sciences Reports Second Quarter FY 2010: 60% Reduction in Operating Expenses and 16% Increase in Product Revenue (37% in Local Currency) Nov 5, 2009
